ArticleSAGE open medicine2026
Association between time-of-day plasma lipid measurements and acute kidney injury in critically ill patients: A retrospective cohort study.
Article in SAGE open medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to evaluate the association between time-of-day differences in blood lipids and acute kidney injury (AKI) in critically ill patients. Methods: This study enrolled 3,227 ICU patients. AKI was defined according to the KDIGO 2012 criteria. Cox regression, restricted cubic splines, Kaplan-Meier analysis, and stratified interaction analysis were used to assess the association between daytime/nighttime levels of high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides and AKI. Results: Each 1 mg/dL increase in HDL-C was associated with a 0.5% decrease in AKI risk [HR 0.995, 95% CI 0.993-0.998, P < 0.001]. Each 1 mg/dL increase in triglyceride was associated with a 0.1% increase in AKI risk [HR 1.001, 95% CI 1.000-1.001, P = 0.004]. LDL-C exhibited an L-shaped nonlinear relationship with AKI. At or below 47 mg/dL (daytime), 58 mg/dL (nighttime), and 48 mg/dL (overall), lower LDL-C was associated with higher AKI risk, whereas above these thresholds, LDL-C was no longer associated with AKI risk [daytime: HR 0.977, 95% CI 0.964-0.991, P < 0.001; nighttime: HR 0.992, 95% CI 0.985-0.998, P = 0.009; overall: HR 0.987, 95% CI 0.980-0.994, P < 0.001]. Conclusion: Higher HDL-C levels were consistently associated with lower AKI incidence within 28 days after ICU admission. Higher nighttime and overall triglyceride levels were associated with higher AKI incidence. An L-shaped nonlinear relationship was observed between LDL-C and AKI risk, with thresholds at 47 mg/dL (daytime), 58 mg/dL (nighttime), and 48 mg/dL (overall). These findings highlight a complex relationship between lipid metabolism and renal outcomes in critically ill patients and warrant confirmation through prospective studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.